Abstract:Abstract Background The p38 alpha mitogen‐activated protein kinase (p38α) pathway is linked to both innate and adaptive immune responses, and is currently under investigation as a target for drug development in the context of Alzheimer’s disease (AD) and other conditions with neuroinflammatory dysfunction (Asih et al., 2020). Preclinical data indicates that p38α inhibition can protect against AD‐associated neuropathology, although the cellular mechanisms and signaling pathways that underlie these effects have not been fully elucidated. Evidence suggests that inhibition of p38α may provide benefit by modulating microglial‐associated neuroinflammatory processes that contribute to the development of AD pathology. The present study tests this hypothesis by assessing early‐stage pathological changes in AD model mice following microglial‐specific knock out (KO) of p38α. Methods KO of p38α in microglia was accomplished in 5‐month‐old C57BL/6J wild‐type and amyloidogenic AD model (APPswe/PS1dE9) mice using a tamoxifen‐inducible Cre/loxP system under control of the Cx3Cr1 promoter. Animals underwent behavioral assessment on the open field test at 7.5 months of age and on the radial arm water maze test at 11 months of age, followed by collection of cortical and hippocampal tissues. Other endpoint measures included quantification of proinflammatory cytokines, assessment of amyloid burden and plaque deposition, and characterization of microglia‐plaque dynamics using a combination of ELISA, immunohistochemical, and immunofluorescent techniques. Results Suppression of microglial p38α did not alter behavioral outcomes, proinflammatory cytokine levels, or overall amyloid plaque burden, but did significantly increase hippocampal levels of soluble Aβ42 and reduced hippocampal colocalization of Iba1 and 6E10 in a subset of microglia in close proximity to plaques. Conclusion This work suggests that rather than reducing inflammation per se, microglial p38α inhibition in the context of early AD‐type amyloid pathology may alter hippocampal microglia‐plaque interactions. Additionally, these results support future investigations of microglial p38α signaling at different stages of disease, as well as the potential relationship between p38α and phagocytic processes in this particular cell‐type. Funding : This work is supported by the National Institutes of Health (RF1 AG064859; F32 AG058456; T32 AG057461).

Upregulation of Astrocytes Protein Phosphatase‐2a Stimulates Astrocytes Migration Via Inhibiting P38 MAPK in Tg2576 Mice

Protein phosphatase 2A regulates the p38 signaling pathway to affect the migration of astrocytes

Early Activation of Astrocytes Does Not Affect Amyloid Plaque Load in an Animal Model of Alzheimer’s Disease

Astrocytic AT1R deficiency ameliorates Aβ-induced cognitive deficits and synaptotoxicity through β-arrestin2 signaling

Serum Amyloid A Inhibits Astrocyte Migration Via Activating P38 MAPK

The Difference in Gliosis Induced by Β-Amyloid and Tau Treatments in Astrocyte Cultures Derived from Senescence Accelerated and Normal Mouse Strains

Quantitative proteomics reveals that PEA15 regulates astroglial Aβ phagocytosis in an Alzheimer's disease mouse model

Morphological and Molecular Alterations of Reactive Astrocytes Without Proliferation in Cerebral Cortex of an APP/PS1 Transgenic Mouse Model and Alzheimer's Patients

PTPA Activates Protein Phosphatase-2A Through Reducing Its Phosphorylation at Tyrosine-307 with Upregulation of Protein Tyrosine Phosphatase 1B.

Activation of Glycogen Synthase Kinase-3 Inhibits Protein Phosphatase-2A and the Underlying Mechanisms

Early loss of microglial p38α MAPK in the APPswe/PS1dE9 mouse model of Alzheimer’s disease alters soluble amyloid beta and reduces microglia co‐localization with amyloid plaques without affecting amyloid‐associated pathology

Astrocyte-derived Lactoferrin Reduces Β-Amyloid Burden by Promoting the Interaction Between P38 Kinase and PP2A Phosphatase in Male APP/PS1 Transgenic Mice

Prostaglandin I2 is Responsible for Ameliorating Prostaglandin E2 Stress in Stimulating the Expression of Tumor Necrosis Factor Α in a Β-Amyloid Protein -Dependent Mechanism.

C6 Glioma-Secreted NGF and FGF2 Regulate Neuronal APP Processing Through Up-Regulation of ADAM10 and Down-Regulation of BACE1, Respectively

P2Y1R silencing in Astrocytes Protected Neuroinflammation and Cognitive Decline in a Mouse Model of Alzheimer's Disease

Astrocyte‐derived lactoferrin reduces Aβ burden by promoting the interaction of p38 and PP2A in male APP/PS1 transgenic mice

Deletion of MyD88 in astrocytes prevents β‐amyloid‐induced neuropathology in mice

IC‐P‐100: Protein Phosphatase‐2a Inhibitor‐2 Up‐regulates P53 and Akt‐implication for a New Mechanism for Alzheimer Neurodegeneration

Astrocyte-derived lactoferrin reduces Aβ burden by promoting the interaction of p38 and PP2A in APP/PS1 transgenic mice

Protein phosphatase-2A inhibitor-2 up-regulates p53 and Akt-implication for a new mechanism for Alzheimer's neurodegeneration

Prostaglandin I2 upregulates the expression of anterior pharynx‐defective‐1α and anterior pharynx‐defective‐1β in amyloid precursor protein/presenilin 1 transgenic mice